FMO5 and diabetic kidney disease: This aligns with mechanistic models of diabetic kidney disease, where hyperglycemia increases ROS formation, activates NADPH oxidases, and upregulates inflammatory cascades (e.g., NF-κB) that mutually amplify ROS production and renal damage [2,3,15].